logo
The Latest: National Guard troops arrive in Washington DC as Trump's federal takeover begins

The Latest: National Guard troops arrive in Washington DC as Trump's federal takeover begins

President Donald Trump took unprecedented steps toward federalizing Washington, D.C. on Monday, saying it's needed to fight crime even as city leaders pointed to data showing violence is down.
He took command of the police department and deployed the National Guard under laws and Constitutional powers that give the federal government more sway over the nation's capital than other cities. Its historically majority Black population wasn't electing its own city council and mayor until 1973, when Republican President Richard Nixon signed the Home Rule Act.
Guard troops start streaming in
National Guard troops are beginning to arrive at the Washington, D.C., armory. They were seen arriving this morning at the Guard's headquarters in the city.
Trump said Monday that in hopes of reducing crime, he would be taking over Washington's police department and activating 800 members of the National Guard. The crime Trump talked about is the same crime that city officials stress is already falling noticeably.
The Republican president, who had himself installed as chairman of the Kennedy Center's board, said in a social media post that the to-be-named nominees are 'GREAT.'
'GREAT Nominees for the TRUMP/KENNEDY CENTER, whoops, I mean, KENNEDY CENTER, AWARDS,' Trump wrote in a social media post. 'They will be announced Wednesday.
'Tremendous work is being done, and money being spent, on bringing it back to the absolute TOP LEVEL of luxury, glamour, and entertainment,' he said, without offering details.
The Kennedy Center Honors program typically tapes in December for broadcast later in the month on CBS.
Trump spurned the performing arts center in his first term after some honorees refused to attend a traditional White House event recognizing their achievements to protest Trump's policies, including those toward the arts. He did not attend the taping of the awards program during those four years in office.
Trump's Tuesday schedule
There is nothing on the president's public schedule today. However, press secretary Karoline Leavitt will hold a briefing at 1 p.m. ET.
Trump's moves toward taking over Washington are unprecedented. Here's what the law says
Trump took command of the police department and deployed the National Guard under laws and Constitutional powers that give the federal government more sway over the nation's capital than other cities. The measure still leaves significant power to the president and Congress, though no president has exercised the police powers before.
Here's a look at what the law says about Trump's actions:
1. Trump activated the National Guard. The president can still call up the National Guard in Washington. His authority is less clear in Los Angeles, where a legal battle continues over his recent deployment of the National Guard despite the objections of Gov. Gavin Newsom.
2. Trump took over the local police. Section 740 of the Home Rule Act allows for the president to take over Washington's Metropolitan Police Department for 48 hours, with possible extensions to 30 days, during times of emergencies. No president has done so before.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China hawks skeptical of Trump chip deal
China hawks skeptical of Trump chip deal

The Hill

time20 minutes ago

  • The Hill

China hawks skeptical of Trump chip deal

Trump on Monday agreed to allow tech giants Nvidia and AMD to secure export licenses to sell their advanced artificial intelligence (AI) chips in China in exchange for a 15 percent cut of the profits. The White House said Tuesday that more such deals could be on the table. The unusual deal doesn't just raise legal questions. Experts say the U.S. should be wary of turning over American-made technology that could boost its adversary's AI capabilities, at a time when the two countries are fiercely competing for dominance. The security concerns appear to be a two-way street. China urged tech companies there to avoid any purchase of Nvidia's H20 chip, citing security issues. The move once again has Trump at odds with Congress's China hawks, who argue the administration is shortchanging America's national security interests to make a buck. Rep. Raja Krishnamoorthi (Ill.), the top Democrat on the House Select Committee on the Chinese Communist Party, in a statement said the most troubling part of the deal was a contradiction at the heart of the policy. 'The administration cannot simultaneously treat semiconductor exports as both a national security threat and a revenue opportunity,' he said. 'By putting a price on our security concerns, we signal to China and our allies that American national security principles are negotiable for the right fee.' The same panel's GOP chair, Rep. John Moolenaar (Mich.), said there are 'questions about the legal basis' for such a deal. 'Export controls are a frontline defense in protecting our national security, and we should not set a precedent that incentivizes the Government to grant licenses to sell China technology that will enhance its AI capabilities,' he said in a statement.

D.C. business leaders warn Trump's crackdown may hurt tourism
D.C. business leaders warn Trump's crackdown may hurt tourism

Axios

time20 minutes ago

  • Axios

D.C. business leaders warn Trump's crackdown may hurt tourism

Restaurant and hospitality groups are pushing back on President Trump 's depiction of the District as a hotbed of "crime, bloodshed, bedlam and squalor," saying the city is safe — and open for business. Why it matters: Several D.C. industry leaders say Trump's rhetoric could deter visitors and hurt a tourism economy already affected by the administration's policies and mass federal firings. By the numbers: 48 groups have canceled or changed their D.C. plans since October due to political concerns, Destination D.C. tells Axios. Their estimated economic loss for the city: more than $61 million, based on projected hotel room nights. State of play: The tourism marketing organization is planning outreach to groups that have booked events or are considering them, according to the Washington Business Journal. That includes sharing stats that show D.C. violent crime has hit a 30-year low. The organization is also joining in on the viral " love letter" to D.C. trend, where locals share real-life portrayals of the city. Reality check: Destination D.C. tells Axios that the estimated 2025 losses due to political reasons represent just 2% of the projected revenue generated for the city, "so there is still a lot of positive production happening for the city." Meanwhile, the Restaurant Association Metropolitan Washington (RAMW) has a message ahead of Summer Restaurant Week, which starts Monday: "D.C. is open for business." "Next week is crucial for some to make it through Labor Day," RAMW CEO Shawn Townsend says of the weeklong event, which aims to draw diners to offset a typical August slowdown. "Folks may be thinking, 'Why go Downtown when I can do Restaurant Week in Bethesda or Tysons?'" Zoom in: RAMW is telling its members to promote positivity on social media and talk directly to diners if they cancel reservations: "It's like any major city — be careful — but D.C. is not a war zone." It's not just fear of crime — the armed presence may hurt, too. "If I'm coming in from out of town, I wouldn't want to bring my family to a city that has National Guard on every corner," says Townsend.

NIH cancels mRNA vaccine contracts, citing lack of public trust
NIH cancels mRNA vaccine contracts, citing lack of public trust

The Hill

time20 minutes ago

  • The Hill

NIH cancels mRNA vaccine contracts, citing lack of public trust

National Institutes of Health Director Jay Bhattacharya claims the federal government recently cancelled millions of dollars' worth of mRNA research contracts because the general public does not trust the technology. Bhattacharya explained the reason behind the abrupt contract cancellations, first, during an episode of Republican political strategist Steve Bannon's podcast 'War Room' last week and again in an opinion piece recently published in The Washington Post. In the article, Bhattacharya called the mRNA platform a 'promising technology' and acknowledged that it may lead to breakthroughs in treatment for diseases like cancer. 'But as a vaccine intended for broad public use, especially during a public health emergency, the platform has failed a crucial test: earning public trust,' he wrote. 'No matter how elegant the science, a platform that lacks credibility among the people it seeks to protect cannot fulfill its public health mission.' Bhattacharya's explanation for the administration's pivot away from mRNA technology differs from that of his boss, Health and Human Services Secretary Robert F. Kennedy Jr. Kennedy announced last week the agency would wind down its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA) and cancel $500 million worth of contracts related to the technology. He said that mRNA technologies funded during the pandemic failed to meet current scientific standards and that the federal government would shift its focus to whole-virus vaccines and novel platforms. Bhattacharya expressed concern in the article about mRNA vaccines' ability to direct human cells to produce spike proteins to trigger an immune response. He argues the scientific community does not have a clear understanding of where mRNA product stays in the body, for how long, and whether other proteins are created in the process. Scott Hensley, a microbiology professor at the University of Pennsylvania's Perelman School of Medicine, told STAT that these are also issues with vaccines that use live but weakened viruses like the measles, mumps, and rubella vaccine, which federal health agencies have deemed safe and effective. 'This is why we complete human clinical studies before vaccines are widely used in humans,' he told the outlet. 'The mRNA and live attenuated vaccine platforms have both proven to be safe and effective in clinical trials.' He blamed public distrust in mRNA on the Biden administration's COVID-19 vaccine mandates during the pandemic. Bhattacharya expressed concern in the article about mRNA vaccines' ability to direct human cells to produce spike proteins to trigger an immune response. He argues the scientific community does not have a clear understanding of where the mRNA product stays in the body, for how long, and whether other proteins are created in the process. 'Science isn't propaganda,' he wrote. 'It's humility. And when public health officials stopped communicating with humility, we lost much of the public, an absolute necessity for any vaccine platform.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store